US Stock MarketDetailed Quotes

REVB Revelation Biosciences

Watchlist
  • 1.2100
  • -0.0400-3.20%
Close Aug 23 16:00 ET
  • 1.2197
  • +0.0097+0.80%
Post 19:58 ET
1.99MMarket Cap-37P/E (TTM)

Revelation Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-24.46%-2.48M
-80.17%-2.84M
35.06%-7.29M
-111.39%-2M
0.85%-1.72M
46.32%-1.99M
67.39%-1.58M
-1.16%-11.22M
67.09%-947.47K
22.52%-1.73M
Net income from continuing operations
-479.34%-8.39M
-143.54%-2.68M
98.89%-120.25K
-82.42%-2.2M
-124.51%-2.63M
21.07%-1.45M
193.09%6.16M
9.65%-10.83M
68.72%-1.21M
61.55%-1.17M
Operating gains losses
98.96%-4.42K
99.12%-68.43K
---8.33M
---68.2K
---92.56K
---423.24K
---7.74M
----
----
----
Depreciation and amortization
15.30%7.22K
-0.02%6.26K
0.00%25.05K
0.00%6.26K
0.00%6.26K
0.00%6.26K
0.02%6.26K
49.26%25.05K
0.00%6.26K
3.15%6.26K
Other non cash items
----
----
----
----
----
----
----
-71.44%14.96K
--0
--0
Change In working capital
3,247.47%5.85M
-355.37%-126.47K
234.36%982.14K
3.80%229.91K
258.96%965.9K
90.57%-185.9K
-101.71%-27.77K
-305.20%-730.97K
-74.08%221.5K
-192.33%-607.62K
-Change in prepaid assets
-165.39%-53.87K
104.94%12.82K
-102.03%-11.56K
-71.27%67.95K
-63.37%97.38K
-24.63%82.38K
-508.52%-259.26K
211.72%569.04K
-74.50%236.5K
121.99%265.85K
-Change in payables and accrued expense
2,301.11%5.91M
-223.53%-210.41K
174.59%911.62K
205.61%141.05K
199.43%868.52K
87.11%-268.28K
-89.90%170.33K
-233.40%-1.22M
181.88%46.15K
-257.58%-873.47K
-Change in other current liabilities
----
----
--0
--0
----
----
----
66.89%-16.75K
--0
--0
-Change in other working capital
--0
16.32%71.13K
234.20%82.07K
--20.92K
--0
--0
--61.15K
---61.15K
----
----
Cash from discontinued investing activities
Operating cash flow
-24.46%-2.48M
-80.17%-2.84M
35.06%-7.29M
-111.39%-2M
0.85%-1.72M
46.32%-1.99M
67.39%-1.58M
-1.16%-11.22M
67.09%-947.47K
22.52%-1.73M
Investing cash flow
Cash flow from continuing investing activities
0
-19.17K
0
0
Net PPE purchase and sale
--0
---19.17K
----
----
----
--0
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
---19.17K
----
----
----
--0
--0
----
----
----
Financing cash flow
Cash flow from continuing financing activities
0
-61.37%5.42M
-7.72%14.03M
0
0
15
30.57%14.02M
89.86%15.2M
5K
4.45M
Net issuance payments of debt
----
----
--0
--0
----
----
----
---796.88K
--0
--0
Net common stock issuance
--0
-61.39%5.42M
215.21%14.03M
--0
--0
--0
93.19%14.03M
641.85%4.45M
--0
--4.45M
Net preferred stock issuance
--0
--0
-200.00%-5K
--0
--0
--0
---5K
-99.93%5K
--5K
--0
Proceeds from stock option exercised by employees
--0
568.42%127
-99.33%34
--0
--0
--15
-99.63%19
--5.09K
--0
--0
Net other financing activities
----
----
----
----
----
----
----
--11.53M
--0
--0
Cash from discontinued financing activities
Financing cash flow
--0
-61.37%5.42M
-7.72%14.03M
--0
--0
--15
30.57%14.02M
89.86%15.2M
--5K
--4.45M
Net cash flow
Beginning cash position
-17.80%14.55M
128.28%11.99M
312.09%5.25M
125.88%13.99M
352.02%15.71M
146.34%17.7M
312.09%5.25M
-71.62%1.27M
49.74%6.2M
-45.45%3.48M
Current changes in cash
-24.46%-2.48M
-79.44%2.56M
69.39%6.74M
-112.51%-2M
-163.12%-1.72M
46.32%-1.99M
110.60%12.45M
223.64%3.98M
67.08%-942.47K
221.70%2.72M
End cash Position
-23.16%12.07M
-17.80%14.55M
128.28%11.99M
128.28%11.99M
125.88%13.99M
352.02%15.71M
146.34%17.7M
312.09%5.25M
312.09%5.25M
49.74%6.2M
Free cash flow
-24.46%-2.48M
-81.39%-2.86M
35.06%-7.29M
-111.39%-2M
0.85%-1.72M
46.32%-1.99M
67.39%-1.58M
0.03%-11.22M
66.90%-947.47K
22.52%-1.73M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -24.46%-2.48M-80.17%-2.84M35.06%-7.29M-111.39%-2M0.85%-1.72M46.32%-1.99M67.39%-1.58M-1.16%-11.22M67.09%-947.47K22.52%-1.73M
Net income from continuing operations -479.34%-8.39M-143.54%-2.68M98.89%-120.25K-82.42%-2.2M-124.51%-2.63M21.07%-1.45M193.09%6.16M9.65%-10.83M68.72%-1.21M61.55%-1.17M
Operating gains losses 98.96%-4.42K99.12%-68.43K---8.33M---68.2K---92.56K---423.24K---7.74M------------
Depreciation and amortization 15.30%7.22K-0.02%6.26K0.00%25.05K0.00%6.26K0.00%6.26K0.00%6.26K0.02%6.26K49.26%25.05K0.00%6.26K3.15%6.26K
Other non cash items -----------------------------71.44%14.96K--0--0
Change In working capital 3,247.47%5.85M-355.37%-126.47K234.36%982.14K3.80%229.91K258.96%965.9K90.57%-185.9K-101.71%-27.77K-305.20%-730.97K-74.08%221.5K-192.33%-607.62K
-Change in prepaid assets -165.39%-53.87K104.94%12.82K-102.03%-11.56K-71.27%67.95K-63.37%97.38K-24.63%82.38K-508.52%-259.26K211.72%569.04K-74.50%236.5K121.99%265.85K
-Change in payables and accrued expense 2,301.11%5.91M-223.53%-210.41K174.59%911.62K205.61%141.05K199.43%868.52K87.11%-268.28K-89.90%170.33K-233.40%-1.22M181.88%46.15K-257.58%-873.47K
-Change in other current liabilities ----------0--0------------66.89%-16.75K--0--0
-Change in other working capital --016.32%71.13K234.20%82.07K--20.92K--0--0--61.15K---61.15K--------
Cash from discontinued investing activities
Operating cash flow -24.46%-2.48M-80.17%-2.84M35.06%-7.29M-111.39%-2M0.85%-1.72M46.32%-1.99M67.39%-1.58M-1.16%-11.22M67.09%-947.47K22.52%-1.73M
Investing cash flow
Cash flow from continuing investing activities 0-19.17K00
Net PPE purchase and sale --0---19.17K--------------0--0------------
Cash from discontinued investing activities
Investing cash flow --0---19.17K--------------0--0------------
Financing cash flow
Cash flow from continuing financing activities 0-61.37%5.42M-7.72%14.03M001530.57%14.02M89.86%15.2M5K4.45M
Net issuance payments of debt ----------0--0---------------796.88K--0--0
Net common stock issuance --0-61.39%5.42M215.21%14.03M--0--0--093.19%14.03M641.85%4.45M--0--4.45M
Net preferred stock issuance --0--0-200.00%-5K--0--0--0---5K-99.93%5K--5K--0
Proceeds from stock option exercised by employees --0568.42%127-99.33%34--0--0--15-99.63%19--5.09K--0--0
Net other financing activities ------------------------------11.53M--0--0
Cash from discontinued financing activities
Financing cash flow --0-61.37%5.42M-7.72%14.03M--0--0--1530.57%14.02M89.86%15.2M--5K--4.45M
Net cash flow
Beginning cash position -17.80%14.55M128.28%11.99M312.09%5.25M125.88%13.99M352.02%15.71M146.34%17.7M312.09%5.25M-71.62%1.27M49.74%6.2M-45.45%3.48M
Current changes in cash -24.46%-2.48M-79.44%2.56M69.39%6.74M-112.51%-2M-163.12%-1.72M46.32%-1.99M110.60%12.45M223.64%3.98M67.08%-942.47K221.70%2.72M
End cash Position -23.16%12.07M-17.80%14.55M128.28%11.99M128.28%11.99M125.88%13.99M352.02%15.71M146.34%17.7M312.09%5.25M312.09%5.25M49.74%6.2M
Free cash flow -24.46%-2.48M-81.39%-2.86M35.06%-7.29M-111.39%-2M0.85%-1.72M46.32%-1.99M67.39%-1.58M0.03%-11.22M66.90%-947.47K22.52%-1.73M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg